Excellent response of cetuximab plus chemotherapy after pembrolizumab monotherapy in metastatic hypopharyngeal cancer: A case report

Patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) typically have an unfavorable prognosis, with a median survival of only 6 to 15 months in most studies. In cases other than local relapse or oligometastases, systemic therapy plays the dominant role. The choice of re...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anh Tuan Pham, Thang Huu Nguyen, Thai Hong Le, Toan Khanh Phan, Anh Phuong Nguyen, Ngoc Minh Le, Thao Thu Vu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-03-01
Schriftenreihe:	Current Problems in Cancer: Case Reports
Schlagworte:	Head and neck squamous cell carcinoma Metastatic hypopharyngeal cancer Cetuximab plus chemotherapy Pembrolizumab
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2666621924000607
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!